Pascal Soriot, CEO of the company noted he was excited about the acceleration of the companys cardiometabolic and obesity pipeline with the licensing agreement for ECC5004, a potential best-in-class oral GLP-1RA. ECC5004 has an oral formulation, in contrast to Novo Nordisks Wegovy (semaglutide) and the recently approved Lillys Zepbound (tirzepatide), which are injectables
Get it wrong and you will waste money, compromise your results, and spend weeks wondering why nothing is working
Introducing a concentrated amount of any potent antioxidant can "shock" the digestive system
This may help maintain the integrity of skin cells and promote overall skin health
Role of metabolically active drugs in the management of ischemic heart disease
With this setup, your entire 1ml (100 units) of solution contains 1000mcg of IGF-1 LR3